XML 70 R57.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2021
Stock-Based Compensation  
Schedule of allocated stock-based compensation

Year Ended December 31, 

(in thousands)

2021

    

2020

    

2019

Equity award expense

$

11,336

$

10,551

$

8,105

Liability award (benefit) expense (1)

 

(816)

 

1,521

 

2,336

Total stock-based compensation expense

$

10,520

$

12,072

$

10,441

(1)In 2021, includes a reversal of prior period expense of $2.1 million during the fourth quarter as the result of revised estimates of performance achievement of our 2019 and 2020 cash-settled performance-based restricted stock units.
Schedule of valuation assumptions

Year Ended December 31, 

2021

2020

2019

Remaining performance period as of grant date (in years)

    

2.8

    

2.9

    

2.9

    

Risk-free interest rate used

 

0.3

%  

1.4

%  

2.6

%  

Grant-date fair value

$

14.30

$

11.33

$

12.91

Schedule of restricted stock, restricted stock unit, performance unit, cash settled restricted stock unit and cash settled performance unit activity

Weighted

Average

Grant Date

Shares

Fair Value

    

(in thousands)

    

Per Share

Non-vested restricted stock, December 31, 2020

 

2,446

$

9.69

Granted (1)

 

1,288

 

11.20

Vested (2)

 

(1,075)

 

9.91

Canceled

 

(81)

 

9.85

Non-vested restricted stock, December 31, 2021 (3)

 

2,578

 

10.35

(1)The weighted average grant date fair value of shares granted during the years ended December 31, 2021, 2020 and 2019 was $11.20, $9.37 and $10.01, respectively.
(2)The total fair value of all awards vested during the years ended December 31, 2021, 2020 and 2019 was $9.1 million, $7.1 million and $9.0 million, respectively.
(3)Non-vested awards as of December 31, 2021 were comprised of 523 cash-settled units and 2,055 stock-settled awards and units.